We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TZAC market cap is 178.91M. The company's latest EPS is USD -1.1903 and P/E is -7.35.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.56M | -7.78M | -6.74M | -12.07M | -10.71M |
| Net Income | -3.52M | -8.12M | -6.6M | -12.44M | -10.49M |
| Year End December 30 2022 | 2019 | 2020 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -153k | -725k | -2.43M | -10.11M | -24.31M |
| Net Income | 574k | 618k | -3.78M | -8.52M | -24.34M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 24.04M | 18.92M | 12.9M | 11.84M | 5.39M |
| Total Liabilities | 3.68M | 6.61M | 7.12M | 10.22M | 13.91M |
| Total Equity | 20.36M | 12.32M | 5.79M | 1.62M | -8.52M |
| Year End December 30 2022 | 2019 | 2020 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 65.65M | 61.02M | 8.76M | 31.4M | 18.92M |
| Total Liabilities | 60.65M | 3.26M | 1.33M | 2.72M | 6.61M |
| Total Equity | 5M | 5M | 7.43M | 28.69M | 12.32M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.27M | -18.96M | -7.95M | -13.27M | -19.45M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 7.77M | 7.79M | 687k | 5.9M | 5.9M |
| Year End December 30 2022 | 2019 | 2020 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -221k | -427k | -3.73M | -10.67M | -18.96M |
| Investing | -64.52M | 5.7M | N/A | N/A | N/A |
| Financing | 65.05M | -5.52M | 12.49M | 31.6M | 7.79M |
| Market Cap | 178.91M |
| Price to Earnings Ratio | -7.35 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.66 |
| Price to Book Ratio | 14.53 |
| Dividend Yield | - |
| Shares Outstanding | 20.45M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.21 (2.4%) |
| Company Name | Tenzing Acquisition Corporation |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://revivapharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
